Taejoon Pharmaceutical Co., Ltd.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Korea, South
- Registered address
- 109-30 Gyeonggidong-ro, Namsa-eup, Cheoin-gu, Yongin-si, Gyeonggi-do 17118, Korea, South (KOR)
- Operations here
- manufacture
- FDA identifiers
- FEI 3008029795 · DUNS 689852091
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2022-10-18
- OAIDrug Quality Assurance2019-10-15
- VAIDrug Quality Assurance2016-11-15
Drugs this plant is listed as making
1 distinct drugs across 1 products name this site in their FDA label.
- CyclosporineSaptalis Pharmaceuticals, LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.